Researcher
Lotte GEYS
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Immunology not elsewhere classified, Bio-informatics and computational biology not elsewhere classified, Neurosciences not elsewhere classified, General and logistic services
Affiliations
- Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From1 Dec 2019 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Dec 2019 → Today - Physiology - Biochemistry - Immunology (Department)
Member
From1 Dec 2019 → 31 Dec 2019 - Immunology - Biochemistry (Research group)
Member
From1 Dec 2019 → 31 Dec 2019
Projects
1 - 2 of 2
- Technology-supported innovative rehabilitationFrom1 Jan 2022 → TodayFunding: FWO scientific research network
- Sub-Grant agreement Model between EMC and Hasselt University in the framework of the EHDEN consortiumFrom15 Feb 2021 → 31 Dec 2022Funding: Foreign public sponsor
Publications
1 - 10 of 10
- Patient level dataset to study the effect of COVID-19 in people with Multiple Sclerosis(2024)
Authors: Hamza KHAN, Lotte GEYS, Peer Baneke, Giancarlo Comi, Liesbet PEETERS
- The Journey of Data Within a Global Data Sharing Initiative: A Federated 3-Layer Data Analysis Pipeline to Scale Up Multiple Sclerosis Research(2023)
Authors: Ashkan PIRMANI, Edward DE BROUWER, Lotte GEYS, Tina PARCIAK, Yves Moreau, Liesbet PEETERS
- Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-beta(2022)
Authors: Steve Simpson-Yap, Ashkan PIRMANI, Edward DE BROUWER, Liesbet PEETERS, Lotte GEYS, Tina PARCIAK, Anne Helme, Jan Hillert, Yves Moreau, Gilles Edan, et al.
- Updated Results of the COVID-19 in MS Global Data Sharing Initiative(2022)
Authors: Steve Simpson-Yap, Ashkan PIRMANI, Tomas Kalincik, Edward DE BROUWER, Lotte GEYS, Tina PARCIAK, Anne Helme, Nick Rijke, Jan A. Hillert, Yves Moreau, et al.
Pages: e200021 - A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination(2021)
Authors: Marina Boziki, Charis Styliadis, Christos Bakirtzis, Eleni Grigoriadou, Aggeliki-Styliani Sintila, Ioannis Nikolaidis, Aliki Vrienniou, Lotte GEYS, Sygkliti-Henrietta Pelidou, Lesley Probert, et al.
- Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis(2021)
Authors: Steve Simpson-Yap, Edward DE BROUWER, Tomas Kalincik, Nick Rijke, Jan A. Hillert, Clare Walton, Gilles Edan, Yves Moreau, Tim Spelman, Lotte GEYS, et al.
Pages: E1870 - E1885 - Updated results of the COVID-19 in MS global data sharing initiative validate consistent associations of anti-CD20 and other reported risk factors with severe COVID-19 outcomes(2021)
Authors: S. Simpson-Yap, Ashkan PIRMANI, Edward DE BROUWER, Lotte GEYS, Tina PARCIAK, A. Helme, N. Rijke, T. Kalincik, J. Hillert, Y. Moreau, et al.
Pages: 741 - 743 - The Multiple Sclerosis Data Alliance Catalogue; Enabling Web-Based Discovery of Metadata from Real-World Multiple Sclerosis Data Sources(2021)
Authors: Lotte GEYS, Tina PARCIAK, Ashkan PIRMANI, Robert McBurney, Hollie Schmidt, Tanja MalbaĊĦa, Tjalf Ziemssen, Arnfin Bergmann, Juan I. Rojas, Edgardo Cristiano, et al.
Pages: 261 - 268 - COVID-19 in people with multiple sclerosis: A global data sharing initiative(2020)
Authors: Liesbet PEETERS, Tina PARCIAK, Clare Walton, Lotte GEYS, Yves Moreau, Edward DE BROUWER, Daniele Raimondi, Ashkan PIRMANI, Tomas Kalincik, Gilles Edan, et al.
Pages: 1157 - 1162 - First results of the COVID-19 in ms global data sharing initiative suggest anti-CD20 dmts are associated with worse covid-19 outcomes(2020)
Authors: S. Simpson-Yap, Edward DE BROUWER, T. Kalincik, N. Rijke, J. Hillert, C. Walton, G. Edan, Y. Moreau, T. Spelman, Lotte GEYS, et al.
Pages: 48 - 49
Linked dataset
1 - 1 of 1